ClinicalTrials.govpublic full text
Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
hiv infection, liver failure, evidence of liver transplantation, pharmacokinetics, raltegravir, immunosuppressive agents, severe hepatic insufficiency, liver transplantation, additional keywords, hepatocarcinoma, hepatitis c, hepatitis b
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 833817
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.